NYSE ARCA | ETF
Under normal market conditions, the fund will invest at least 80% of its net assets plus any borrowings for investment purposes in equity securities of companies principally engaged in the health sciences group of industries.
While the fund will invest primarily in companies providing products and services for human health, it may also invest in companies whose products or services relate to the growth or survival of animals and plants.
Top 20 Holdings
| Asset | Name | Sector | Industry | Weight |
|---|---|---|---|---|
| MRK | Merck & Company Inc | Healthcare | Drug Manufacturers - General | 5.58% |
| JNJ | Johnson & Johnson | Healthcare | Drug Manufacturers - General | 5.24% |
| GILD | Gilead Sciences Inc | Healthcare | Drug Manufacturers - General | 4.99% |
| EW | Edwards Lifesciences Corp | Healthcare | Medical Devices | 4.86% |
| TMO | Thermo Fisher Scientific Inc | Healthcare | Diagnostics & Research | 3.86% |
| DHR | Danaher Corporation | Healthcare | Diagnostics & Research | 3.76% |
| COR | Cencora Inc. | Healthcare | Medical Distribution | 3.74% |
| WAT | Waters Corporation | Healthcare | Diagnostics & Research | 3.71% |
| BIIB | Biogen Inc | Healthcare | Drug Manufacturers - General | 3.71% |
| AMGN | Amgen Inc | Healthcare | Drug Manufacturers - General | 3.49% |
| CRL | Charles River Laboratories | Healthcare | Diagnostics & Research | 3.28% |
| GH | Guardant Health Inc | Healthcare | Diagnostics & Research | 3.01% |
| VRTX | Vertex Pharmaceuticals Inc | Healthcare | Biotechnology | 2.97% |
| MTD | Mettler-Toledo International Inc | Healthcare | Diagnostics & Research | 2.74% |
| ROG | Roche Holding AG | Healthcare | Drug Manufacturers - General | 2.70% |
| MRNA | Moderna Inc | Healthcare | Biotechnology | 2.63% |
| DXCM | DexCom Inc | Healthcare | Medical Devices | 2.58% |
| XTSLA | BlackRock Cash Funds Treasury SL Agency | 2.50% | ||
| PFE | Pfizer Inc | Healthcare | Drug Manufacturers - General | 2.37% |
| BRKR | Bruker Corporation | Healthcare | Medical Devices | 2.34% |